Takeuchi, Masashi
Collins, Toby
Lipps, Clement
Haller, Mathieu
Uwineza, Josiane
Okamoto, Nariaki
Nkusi, Richard
Marescaux, Jacques
Kawakubo, Hirofumi
Kitagawa, Yuko
Gonzalez, Cristians
Mutter, Didier
Perretta, Silvana
Hostettler, Alexandre
Dallemagne, Bernard
Article History
Received: 28 September 2022
Accepted: 5 February 2023
First Online: 24 February 2023
Declarations
:
: Dr. Yuko Kitagawa received lecture fees from CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD., ASAHI KASEI PHARMA CORPORATION, Otsuka Pharmaceutical Factory Inc., SHIONOGI & CO., LTD., Nippon Covidien Inc., ONO PHARMACEUTICAL CO., LTD., Bristol-Myers Squibb K.K. Dr. Yuko Kitagawa was supported by grants from CHUGAI PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD., Yakult Honsha Co. Ltd., AsahiKASEI Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., ONO PHARMACEUTICAL CO., LTD., TSUMURA & CO., Kyouwa Hakkou Kirin Co., Ltd., DAINIPPON SUMITOMO PHARMA Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., MEDICON INC., KAKEN PHARMACEUTICAL CO. LTD., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., TEIJIN PHARMA LIMITED, NIHON PHARMACEUTICAL CO., LTD., and Nippon Covidien Inc. Dr. Yuko Kitagawa held an endowed chair provided by CHUGAI PHARMACEUTICAL CO., LTD., and TAIHO PHARMACEUTICAL CO., LTD., outside the submitted work. Drs. Masashi Takeuchi1, Toby Collins, Clement Lipps, Mathieu Haller, Josiane Uwineza, Nariaki Okamoto, Richard Nkusi, Jacques Marescaux, Hirofumi Kawakubo, Cristians Gonzalez, Didier Mutter, Silvana Perretta, Alexandre Hostettler, and Bernard Dallemagne have no conflicts of interest or financial ties to disclose.